Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation

Authors:

Edwards SJ, Barton S, Thurgar E and Trevor N.

Publication Type:

Journal Article

Publication Name:

Health technology assessment

Citation:

Edwards SJ, Barton S, Thurgar E and Trevor N. Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation. Health Technol Assess. 2015;19(7):1-480.


Link to publication ⟶

⟵ Back to Search Results